Bogor Update on Internal Medicine

Plenary Lecture

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The challenge of the new treatment in autoimmune disease


Symposium 1

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The application of TECOS: CV safety in clinical practice

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Powerful efficacy and implementation in daily practice of early combination of sitagliptin / metformin in type 2 diabetes mellitus


Symposium 2

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Update management and diagnostic of typhoid fever

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Lactobaccilus as immunomodulator, is it true? Fact or Myth?

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 2


Symposium 3

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

-Slide not available-

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Reaching better glycaemic control by intensifying therapy insulin with premixed


Symposium 4

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Management of community acquired pneumonia

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Role of levofloxacin in community acquired pneumonia

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

DIscussion symposium 4


Symposium 5

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Dyslipidemia management: In very high risk patients

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The current concept of rosuvastatin: Role in cardiovascular disease


Symposium 6

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

-Slide not available-

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The most valuable of immunomodulator in daily practice

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 6


Symposium 7

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

-Slide not available-

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The role of LMWH for VTE prophylaxis in medically Ill patients

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 7


Symposium 8

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Beta blocker agent with nitric oxide benefit to get the goal in cardiovascular disease management

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

-Slide not available-

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 8


Meet the expert

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion: Meet the expert


Plenary Lecture

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Identifikasi masalah etika dalam klinik


Symposium 9

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

New direction in the treatment of T2DM : What you need to know about the SGLT2 inhibitor

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Why should you be concerned about Cardio-Metabolic risk- Practical strategies for healthcare physicians

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 9


Symposium 10

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Osteoartritis management

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Aspek kedokteran fisik dan rehabilitasi pada penanganan osteoartritis

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 10


Symposium 11

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Role of gliclazide MR today: An efficacy and safety you can trust

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Improving hypertension management with evidence based combination therapy: Interest of specific combination

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 11


Symposium 12

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

A closer look of Linagliptin: The novel DPP4-inhibitor with a broad action & powerful efficacy in T2DM management

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The powerful 24hr BP reductions with

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 12


Symposium 13

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Early done combination approach the reason behind focus on glimepiride+metformin

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Antioxidant In the prevention of diabetic complication: Needed or useless?

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 13


Symposium 14

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Approach to optimize and intensify insulin therapy: When is the time and what are the options?

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Addressing current unmet medical needs of basal insulin therapy in the diabetes management: A new insights?

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 14


Symposium 15

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Diagnosis osteoporosis

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Management osteporosis

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 15


Symposium 16

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Management of DMT2 during ramadan: What evidences say?

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

The rationale to use combination therapy: When to start and what to expect

MOV0A0.MOD_snapshot_00.00_[2015.06.12_17.08.34]+

Discussion symposium 16


CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending